New anticancer medicine Jevtana designated as orphan drug
The company also said Jevtana is expected to be available as a marketed product within this year as a registration dossier of Jevtana is under regulatory revi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
